siberia

Siberian-made EpiVacCorona Covid-19 vaccine creates antibodies in 100% of participants in initial small-scale trial
- 3 years ago
- Updates
All volunteers vaccinated by Siberia’s Vector Research Center’s EpiVacCorona coronavirus formula have developed antibodies. The